1. Colsevelam as an add-on treatment for control of dyslipidemia and hyperglycaemia in Type 2 Diabetes. Sandhu S, Mandana Moosavi, Kamran Golmohammadi, Francis G. CDJ June 2015
2. Effect of autoimmunity Risk Loci on the honeymoon phase in Type 1 Diabetes; M. Moosavi, Constantin Polychronakos. Pediatric Diabetes 2017 Sep; 18(6): 459-462
3. Audit of Atypical Femoral fractures and a description of some of their features. Lian K, Sandhu S, Moosavi M, Can Assoc Radiol J, 2016 Feb 67 (1): 69-75
4. The effect of Type 2 diabetes risk loci on insulin requirements in Type 1 diabetes. M. Moosavi, Jade Seguin, Constantin Polychronakos. Horm Res Pediatric 2012; 77: 305-3085.
6. Mechanism of action of islet neogenesis associated protein ( INGAP): Comparison of the full length recombinant protein and a bio active peptide. Maria Petropavlovskaisa, Jamal Daoud, M. Moosavi, Jieping Ding, Lawrence Rosenberg. AM J Physiol Endocrinol Metab 2012 Oct 1; 303 (7); E917-27